Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 9/20 | 0.68 |
| ▸ | TSHR | P16473 | 4/20 | 0.68 |
| ▸ | MEN1 | O00255 | 1/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.68 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.68 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA3 | P07451 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA6 | P23280 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2679054 | 1.00 | DNM1 (0.68) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL16265487 | 1.00 | DNM1 (0.68) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL10426271 | 1.00 | DNM1 (0.68) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL3279147 | 1.00 | DNM1 (0.68) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL8158097 | 1.00 | DNM1 (0.68) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL8980572 | 1.00 | DNM1 (0.68) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL10479136 | 1.00 | DNM1 (0.68) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL7610794 | 1.00 | DNM1 (0.68) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL6560896 | 1.00 | DNM1 (0.68) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL1673890 | 1.00 | DNM1 (0.68) | DNM1TSHRMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118834075-A | Ceramic powder and preparation method and application thereof | 南充三环电子有限公司 | 2024-10-25 | — | — | CN | claimed |
| CN-118834075-A | Ceramic powder and preparation method and application thereof | 南充三环电子有限公司 | 2024-10-25 | — | — | CN | disclosed |
| CN-118373970-A | Conjugated polymer based on triphendioxazine imide and preparation method and application thereof | 大连理工大学 | 2024-07-23 | — | — | CN | disclosed |
| US-12018041-B2 | Metal tin cyclized perylene diimide derivative, method for preparing the same, and method for using the same | DALIAN UNIVERSITY OF TECHNOLOGY (CN) | 2024-06-25 | — | — | US | disclosed |
| CN-116836183-A | Tribenzodithiazide imide derivative, preparation method and application | 大连理工大学 | 2023-10-03 | — | — | CN | disclosed |
| CN-114634520-B | Triphenyl dioxazine compound, its coordination complex and preparation method | 大连理工大学 | 2023-07-14 | — | — | CN | disclosed |
| WO-2021135133-A1 | METAL TIN CYCLIZED PERYLENE IMIDE DERIVATIVES, PREPARATION METHOD THEREFOR AND USE THEREOF | 大连理工大学 | 2021-07-08 | — | — | WO | disclosed |
| US-20210198292-A1 | METAL TIN CYCLIZED PERYLENE DIIMIDE DERIVATIVE, METHOD FOR PREPARING THE SAME, AND METHOD FOR USING THE SAME | DALIAN UNIVERSITY OF TECHNOLOGY (CN) | 2021-07-01 | — | — | US | disclosed |
| CN-110105370-B | Preparation method of dithieno-benzene diimide | 南京邮电大学 | 2020-12-01 | — | — | CN | disclosed |
| CN-110105370-A | A kind of preparation method of Dithiophene acene imidodicarbonic diamide | 南京邮电大学 | 2019-08-09 | — | — | CN | disclosed |
| US-5514683-A | LIGANDS FKOR CHOLECYSTOKININ OR GASTRIN RECEPTORS | JAMES BLACK FOUNDATION LIMITED (GB) | 1996-05-07 | — | — | US | disclosed |
| EP-0626942-A1 | BICYCLO 2.2.2.]OCTANE DERIVATIVES AS CHOLESTOCYSTOKININ INHIBITORS. | BLACK JAMES FOUNDATION (GB) | 1994-12-07 | — | — | EP | disclosed |
| WO-1993016982-A1 | BICYCLO[2.2.2.]OCTANE DERIVATIVES AS CHOLESTOCYSTOKININ INHIBITORS | JAMES BLACK FOUNDATION LIMITED (GB) | 1993-09-02 | — | — | WO | disclosed |
| EP-0322209-B1 | COMPOUNDS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1993-02-10 | — | — | EP | disclosed |
| US-4954339-A | ANTICHOLESTEROL AGENTS, SEQUESTERING | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1990-09-04 | — | — | US | disclosed |
| CN-1034550-A | Compound | SMITH KLINE FRENCH LAB (GB) | 1989-08-09 | — | — | CN | disclosed |
| US-4845130-A | REDUCTION OF SERUM CHOLESTEROL AND TRIGLYCERIDES | UNITED STATES BORAX & CHEMICAL CORPORATION (US) | 1989-07-04 | — | — | US | disclosed |
| WO-1989005828-A1 | COMPOUNDS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1989-06-29 | — | — | WO | disclosed |
| EP-0322209-A1 | Compounds | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1989-06-28 | — | — | EP | disclosed |
| US-4260497-A | DETERGENTS | COLGATE-PALMOLIVE COMPANY (US) | 1981-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12018041-B2 | Metal tin cyclized perylene diimide derivative, method for preparing the same, and method for using the same | IDH3A, CRBN, IDH2 | DNM1 1456/4885TSHR 956/4885MEN1 27/4885 |
| US-20210198292-A1 | METAL TIN CYCLIZED PERYLENE DIIMIDE DERIVATIVE, METHOD FOR PREPARING THE SAME, AND METHOD FOR USING THE SAME | IDH3A, CRBN, IDH2 | DNM1 1456/4885TSHR 956/4885MEN1 27/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.